Eurograd message

Message posted on 19/02/2021

4S 2021 CfP Open Panel ‘Transforming the Development & Governance of Pharmaceuticals’

                Dear Colleague,



We are inviting submissions to the following panel (#195) at the next 4S
conference in October 2021: ‘*Transforming the Development & Governance of
Pharmaceuticals*’



We aim to bring together scholars working on the different steps in the
life of pharmaceuticals: their manufacturing, evaluation, and licensing,
and how these processes may be governed and contested.



*Abstract submissions are due 8 March 2021 (see details below).*





*Transforming the Development & Governance of Pharmaceuticals*



Major changes are underway within the pharmaceutical sector that are
associated with shifts in research, innovation and business models from
blockbuster products intended for large patient populations to more niche
products designed for smaller, more targeted populations. Innovation is
underway in how drugs are being researched and developed, and how they are
being manufactured, used, evaluated, licensed and paid for. While some of
these changes are tied to genomics and the rise of personalized medicine,
others result of patient activism and disease politics. These technical and
political developments put pressure on public regulators and payers,
resulting in novel forms of governance, including the use of real-world
data and conditional reimbursement.



This panel builds on STS scholarship on the socio-technical production of
pharmaceutical knowledge, as well as its material and biopolitical impacts.
We invite papers from a range of international perspectives that critically
analyze these transformations, as well as those that highlight forms of
alternative pharmaceutical practices and methods that are more sustainable
and offer more just and equitable access to treatments. Topics may include
but are not limited to:



   - Forms of open pharmaceutical innovation
   - Industry dynamics and changing business models
   - Patient groups and new forms of knowledge production
   - R&D partnerships across public, not-for-profit and/or private sector
   - Drug repurposing and off-label use
   - Changing regulatory knowledge and forms of evaluation
   - Pharmaceutical pricing and access

·         Novel access arrangement and alternative regulatory frameworks
for coverage

   - Future health care system sustainability and social solidarity



The conference call for submissions webpage here:
https://www.4sonline.org/meeting/call-for-submissions/ and the submission
portal here: https://convention2.allacademic.com/one/ssss/ssss21/



Please let us know if you have any questions, and feel free to send this
invitation to any other colleagues who might be interested in submitting.



On behalf of the panel organizers:


Conor Douglas (York, Toronto, Canada) cd512@yorku.ca

Paul Martin (Sheffield, UK) paul.martin@sheffield.ac.uk

Tineke Kleinhout-Vliek (Utrecht) t.h.kleinhout-vliek@uu.nl
_______________________________________________
EASST's Eurograd mailing list
Eurograd (at) lists.easst.net
Unsubscribe or edit subscription options: http://lists.easst.net/listinfo.cgi/eurograd-easst.net

Meet us via https://twitter.com/STSeasst

Report abuses of this list to Eurograd-owner@lists.easst.net
            
view formatted text
Follow by Email